The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects

European Journal of Clinical Pharmacology

Volumn 58, Issue 4, 2002, Pages 247-252

  Yates, R ^a   Tateno, M ^b   Nairn, K ^a   Ikegami, A ^a   Dane, A ^a   Kemp, J ^a  

^a ASTRAZENECA   (United Kingdom)

^b AstraZeneca ^*

Author keywords

Migraine; Pharmacokinetics; Zolmitriptan

Indexed keywords

DRUG METABOLITE; ZOLMITRIPTAN; OXAZOLIDINONE DERIVATIVE; SEROTONIN AGONIST; TRYPTAMINE DERIVATIVE;

ABDOMINAL PAIN; ADULT; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; JAPAN; MALE; MIGRAINE; NAUSEA; NORMAL HUMAN; PHARYNGITIS; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; URINARY EXCRETION; ASIAN; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; SMOKING; URINE;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; CAUCASOID RACE; COMPARATIVE STUDY; FEMALE; HUMAN; JAPAN; MALE; MIDDLE AGE; MONGOLOID RACE; OXAZOLIDINONES; SEROTONIN AGONISTS; SMOKING; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MIDDLE AGED; TRYPTAMINES;

EID: 0036020407     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-002-0461-6     Document Type: Article

References (18)

1. The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers
2. The clinical pharmacokinetics of zolmitriptan
3. Determination of the human hepatic cytochrome P450 enzymes involved in zolmitriptan and N-desmethyl zolmitriptan metabolism in man
4. Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)
5. A form of cytochrome P450 in man orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking
6. Detection of three genetic polymorphisms in the 5′-flanking region and intron 1 of human CYP1A2 in the Japanese population
7. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans
8. Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities
9. The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: A comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate
10. Interindividual variations in human liver cytochrome P450 enzymes involved with the oxidation of drugs carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
11. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90)
12. The metabolism of zolmitriptan: The effects of an inducer and an inhibitor on cytochrome P450 on its pharmacokinetics in healthy volunteers
13. The pharmacokinetics and effects on blood pressure of multiple doses of the novel antimigraine drug zolmitriptan (311C90) in healthy volunteers
14. The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers
15. 1B/1D agonist
16. 1B/1D agonist: An overview of efficacy
17. 1B/1D agonist zolmitriptan in healthy young and elderly men and women
18. Racial and gender differences in N-acetyltransferase, xanthine oxidase and CYP1A2 activities